Sign in
Enrolling by invitationNo phase

Immune reactions after eating gluten in people with celiac disease and healthy volunteers

Looks at immune responses after eating gluten powder in celiac disease and healthy controls.

Key facts

Who runs it
Boston Children's Hospital
Where
Aurora and Boston, United StatesSee the 2 sites
Trial code
Registry title
Immune Responses to Gluten
Status
Enrolling by invitation
People taking part
400 people, planned
Started
15 Jan 2023
Expected to end
30 Sept 2029
Type of study
Interventional, 2 groups
Treatments tested
  • Gluten Powder
Record updated
11 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with celiac disease and healthy people without it. Everyone eats one dose of gluten powder so researchers can study immune responses.

Age
2 Years to 101 Years
Sex
All sexes can join.
Disease stage
People in the celiac disease group need a diagnosis confirmed by blood tests (serology) and/or a tissue sample (histology). Healthy people without celiac disease can also join.
Earlier treatment
Everyone must have been on a gluten-free diet for 4 weeks or more. Everyone must be willing to eat gluten for the research.

Main reasons for not taking part

  • Pregnancy
  • Wheat allergy
  • Type 1 diabetes
  • BMI z-score < -2 (very low weight for age)
  • More than mild symptoms after gluten exposure while on a gluten-free diet

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • On a gluten-free diet for ≥ 4 weeks
  • Willing to consume gluten for research
  • For the celiac disease arm, diagnosis confirmed by serology and/or histology

Who cannot take part

  • Wheat allergy
  • Type 1 diabetes
  • History of more than minimal symptoms following gluten exposure on a gluten-free diet
  • Comorbid condition that in the opinion of the investigator would interfere with study participation or would confound study results
  • Pregnancy
  • BMI z-score < -2

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 101 years old?

Where in United States

  • Children's Hospital ColoradoAurora, United StatesEnrolling by invitation
  • Boston Children's HospitalBoston, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.

The 2 groups in the trial

  • Celiac DiseaseTreatment being tested

    Individuals with a confirmed diagnosis of celiac disease based on serology and/or histology

    Treatment: Gluten Powder

  • Healthy ControlsTreatment being tested

    Individuals without a diagnosis of celiac disease

    Treatment: Gluten Powder

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Changes in Serum IL-2 Levels Following a Single Oral Dose of Gluten
Plain-language title
Immune reactions after eating gluten in people with celiac disease and healthy volunteersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05209568, who can take part
Record updated
11 September 2026